JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kazuhiro Ueda
Kimikazu Hamano
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, T.-S.
Right arrow Articles by Hamano, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, T.-S.
Right arrow Articles by Hamano, K.
Related Collections
Right arrow Coronary disease
Right arrow Peripheral vascular

J Thorac Cardiovasc Surg 2010;139:459-465
© 2010 The American Association for Thoracic Surgery

Evolving Technology/Basic Science

Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure

Tao-Sheng Li, MD, PhD*, Masayuki Kubo, PhD, Kazuhiro Ueda, MD, PhD, Masanori Murakami, MD, PhD, Akihito Mikamo, MD, PhD, Kimikazu Hamano, MD, PhD

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan

Received for publication January 13, 2009; revisions received July 1, 2009; accepted for publication July 22, 2009.

* Address for reprints: Tao-Sheng Li, MD, PhD, Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan 755-8505. (Email: litaoshe{at}yamaguchi-u.ac.jp).

Objective: The implantation of autologous bone marrow–derived cells has been used for the treatment of ischemic diseases, but obvious interindividual differences were observed in the improvement of regional perfusion and cardiac function after treatment. We examined the angiogenic potency of bone marrow cells from patients with different clinical backgrounds.

Methods: Bone marrow cells were collected from 25 patients scheduled to undergo sternotomy for various surgical procedures. We examined the quality of bone marrow cells and investigated their angiogenic potency by using an ischemic limb model in mice with severe combined immunodeficiency.

Results: When compared with their control cohort, bone marrow cells from patients with advanced age, renal failure, or anemia had significantly less c-kit– and CD34-positive stem cells (P < .05) and showed significantly lower vascular endothelial growth factor production and colony-forming units in culture (P < .05). Furthermore, the implantation of bone marrow cells from patients with advanced age, renal failure, or anemia into the ischemic limbs of mice also resulted in significantly worse blood flow recovery and clinical score when compared with the implantation of bone marrow cells from their control cohorts (P < .05). However, the bone marrow cells from patients with diabetes and hypertension did not show significant impairment of angiogenic potency when compared with their control cohorts.

Conclusions: The quality and angiogenic potency of bone marrow cells differs among patients. Advanced age, renal failure, and anemia should be the risk factors related to poor angiogenic potency of bone marrow cells for the treatment of ischemic diseases.

Abbreviations and Acronyms SCID mice = mice with severe combined immunodeficiency; VEGF = vascular endothelial growth factor






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2010 by The American Association for Thoracic Surgery.